BPIA secures plant biostimulant priorities in U.S. House Farm Bill

May 21, 2024

The Biological Products Industry Alliance (BPIA) applauds the U.S. House Committee on Agriculture for unveiling its full 2024 Farm Bill text and including regulatory reforms inspired by the Plant Biostimulant Act, H.R. 1472.

These reforms, which exclude plant biostimulants from regulation under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), “bring clarity and stimulate innovation in the plant biostimulant industry,” noted the BPIA.

“We commend the Committee’s leadership in supporting agricultural innovation,” said John Dunmore, Director of Government and External Affairs for BPIA. “This commonsense approach aligns regulation with scientific understanding, fostering sustainable practices and benefiting growers, consumers, and the environment.”

BPIA has long advocated for science-based regulations supporting biological product growth. In a news release, the BPIA stated these reforms represent a “significant step toward creating a supportive regulatory environment for agricultural technologies.”

BPIA also urges the House Committee on Agriculture to “swiftly consider and pass their version of the farm bill” while keeping the plant biostimulant language intact. “It is also urgent that the Senate publicizes and considers its final version of the 2024 Farm Bill in a timely fashion.”

Related Posts